You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BBIO Exercise Disclosure
Kumar Neil · SEC Form 4 · Filed Aug 18, 2026
Exercise
Calculated transaction value
$0
Kumar Neil Chief Executive Officer
BBIO
BridgeBio Pharma
BBIO
Transaction date
Aug 16, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed 2 days later
BBIO daily price context
Close on/before transaction
$79.86
Aug 14, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 6,520 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001470831-26-000836
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$2.89M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | Not reported |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | Not reported |
| Bridgebio Pharma, Inc. BBIO | Disposition | Aug 16, 2026 | $2.89M |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | Not reported |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | Not reported |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO Current | Exercise | Aug 16, 2026 | $0 |